| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author index
|
|
|
2005
|
3 |
1 |
p. 41-43
3 p.
|
artikel
|
| 2 |
O-49. Accuracy of intraoperative radiology in assessing tumour proximity to resection margins during breast conserving surgery
|
|
|
2005
|
3 |
1 |
p. 16-
1 p.
|
artikel
|
| 3 |
O-53. Accuracy of mammography in predicting histological extent of DCIS
|
|
|
2005
|
3 |
1 |
p. 17-
1 p.
|
artikel
|
| 4 |
O-32. A computer programme to calculate for the individual: the expected improvement in survival chance from adjuvant therapies
|
|
|
2005
|
3 |
1 |
p. 10-11
2 p.
|
artikel
|
| 5 |
O-52. Activated c-Src in ductal carcinoma in situ correlates with high grade and HER2 expression
|
|
|
2005
|
3 |
1 |
p. 17-
1 p.
|
artikel
|
| 6 |
O-122. Age related quality of life (QoL) benefits: results from the Almanac Trial with 18 months follow-up
|
|
|
2005
|
3 |
1 |
p. 39-
1 p.
|
artikel
|
| 7 |
O-116. A molecular analysis of the relationship between ERα and ERβ in primary breast cancer
|
|
|
2005
|
3 |
1 |
p. 37-
1 p.
|
artikel
|
| 8 |
O-14. A multi-centre, randomized, double blind, controlled trial of prophylactic antibiotic use in surgery (PAUS) for primary breast cancer
|
|
|
2005
|
3 |
1 |
p. 5-
1 p.
|
artikel
|
| 9 |
O-67. An audit of clinical and radiological characteristics of medullary carcinomas of the breast
|
|
|
2005
|
3 |
1 |
p. 21-22
2 p.
|
artikel
|
| 10 |
O-108. An audit of outcome of women having immediate post mastectomy latissimus dorsi myocutaneous flap breast reconstruction (IPMLDBR)
|
|
|
2005
|
3 |
1 |
p. 34-
1 p.
|
artikel
|
| 11 |
O-16. An audit of subcutaneous mastectomy for breast cancer
|
|
|
2005
|
3 |
1 |
p. 5-
1 p.
|
artikel
|
| 12 |
O-9. An audit phase of 511 unselected consecutive cases shows that sentinel node biopsy with blue dye alone is safe and accurate
|
|
|
2005
|
3 |
1 |
p. 3-
1 p.
|
artikel
|
| 13 |
O-21. A prospective investigation into venous changes and lymphoedema in breast cancer
|
|
|
2005
|
3 |
1 |
p. 7-
1 p.
|
artikel
|
| 14 |
O-22. A randomised controlled trial: comparing the psychological effects of routine follow up versus point of need access only at 2 years post diagnosis of breast cancer
|
|
|
2005
|
3 |
1 |
p. 7-
1 p.
|
artikel
|
| 15 |
O-119. A review of the pathological features of 86 LCIS cases — to determine diagnostic accuracy
|
|
|
2005
|
3 |
1 |
p. 38-
1 p.
|
artikel
|
| 16 |
O-112. Aromatase inhibitors (AI) versus Tamoxifen for ER-positive breast cancer — a meta-analysis
|
|
|
2005
|
3 |
1 |
p. 35-36
2 p.
|
artikel
|
| 17 |
O-113. Aromatase inhibitors upfront: the switch of 2–5 years or extended adjuvant — how do we choose?
|
|
|
2005
|
3 |
1 |
p. 36-
1 p.
|
artikel
|
| 18 |
O-123. Axillary relapse following axillary surgery
|
|
|
2005
|
3 |
1 |
p. 39-
1 p.
|
artikel
|
| 19 |
O-39. Better survival and distinguishing pathological features of breast cancer in patients with BRCA-1 germline mutations
|
|
|
2005
|
3 |
1 |
p. 13-
1 p.
|
artikel
|
| 20 |
O-89. Biochemical properties of breast cancer derived exosomes
|
|
|
2005
|
3 |
1 |
p. 28-29
2 p.
|
artikel
|
| 21 |
O-105. Bioinformatic analysis using TMAS in breast cancer: age-related heterogeneity within grade 3, node negative disease
|
|
|
2005
|
3 |
1 |
p. 33-34
2 p.
|
artikel
|
| 22 |
O-7. Blue dye sentinel node (SNL) biopsy is an effective technique for staging axilla in breast cancer patients
|
|
|
2005
|
3 |
1 |
p. 3-
1 p.
|
artikel
|
| 23 |
O-118. Breast carcinomas with basal/myoepithelial differentiation: a review of morphology and immunophenotypical analysis
|
|
|
2005
|
3 |
1 |
p. 38-
1 p.
|
artikel
|
| 24 |
O-12. Can axillary staging be avoided in a selected group of older women with small non-high grade breast tumours?
|
|
|
2005
|
3 |
1 |
p. 4-
1 p.
|
artikel
|
| 25 |
O-74. Caveolin-1 expression in Tamoxifen-sensitive and resistant MCF-7 breast cancer cells
|
|
|
2005
|
3 |
1 |
p. 24-
1 p.
|
artikel
|
| 26 |
O-65. Chromosome 16 tumour suppressor gene in breast cancer: where are we now?
|
|
|
2005
|
3 |
1 |
p. 21-
1 p.
|
artikel
|
| 27 |
O-103. Clinical value of CEA, CA 15-3 and TPS in breast cancer
|
|
|
2005
|
3 |
1 |
p. 33-
1 p.
|
artikel
|
| 28 |
O-6. Combination blue dye sentinel lymph node biopsy and axillary node sampling: the Edinburgh experience
|
|
|
2005
|
3 |
1 |
p. 2-
1 p.
|
artikel
|
| 29 |
O-42. Comparison of local recurrence between screen detected and symptomatic breast cancer
|
|
|
2005
|
3 |
1 |
p. 14-
1 p.
|
artikel
|
| 30 |
O-51. Cox-2 inhibition increases apoptosis in human ductal carcinoma in situ (DCIS) of the breast in a xenograft model
|
|
|
2005
|
3 |
1 |
p. 16-17
2 p.
|
artikel
|
| 31 |
O-59. Critical appraisal of the nomogram for predicting non-sentinel lymph node metastasis
|
|
|
2005
|
3 |
1 |
p. 19-
1 p.
|
artikel
|
| 32 |
O-85. Definition of the evolutionary pathway to acquired Docetaxel resistance
|
|
|
2005
|
3 |
1 |
p. 27-
1 p.
|
artikel
|
| 33 |
O-66. Differences in presentation of lobular, ductal, mixed and special type breast cancer
|
|
|
2005
|
3 |
1 |
p. 21-
1 p.
|
artikel
|
| 34 |
O-47. Does mastectomy for involved margins confer advantage over further local excision to clear margins following conservative surgery in early breast cancer?
|
|
|
2005
|
3 |
1 |
p. 15-
1 p.
|
artikel
|
| 35 |
O-76. Does oestrogen receptor β expression influence survival in breast cancer?
|
|
|
2005
|
3 |
1 |
p. 24-25
2 p.
|
artikel
|
| 36 |
O-93. Does the survival of interval cancers vary according to subtype and time since previous mammogram?
|
|
|
2005
|
3 |
1 |
p. 30-
1 p.
|
artikel
|
| 37 |
O-4. Does timing of breast cancer surgery in relation to the menstrual cycle phase affect prognosis? The Yorkshire Breast Cancer Group Intervention, Timing and Survival Study
|
|
|
2005
|
3 |
1 |
p. 2-
1 p.
|
artikel
|
| 38 |
O-88. Effect of grape procyanidins on intracellular calcium levels in human breast cancer MCF 7 cells
|
|
|
2005
|
3 |
1 |
p. 28-
1 p.
|
artikel
|
| 39 |
O-121. End of 4 node sampling? Comparative morbidy versus sentinel lymph node biopsy in the ALMANAC trial
|
|
|
2005
|
3 |
1 |
p. 39-
1 p.
|
artikel
|
| 40 |
O-75. Expressions of Cyclin B1 and CKS2 in breast cancers go down after short-term treatment with aromatase inhibitors
|
|
|
2005
|
3 |
1 |
p. 24-
1 p.
|
artikel
|
| 41 |
O-54. Factors predicting recurrence in DCIS after breast conserving surgery with clear margins
|
|
|
2005
|
3 |
1 |
p. 17-18
2 p.
|
artikel
|
| 42 |
O-97. Follow-up after excision of radial scars and complex sclerosing lesions of the breast
|
|
|
2005
|
3 |
1 |
p. 31-
1 p.
|
artikel
|
| 43 |
O-81. Fulvestrant in pretreated patients with advanced breast cancer: experience from the Institut Bergoni
|
|
|
2005
|
3 |
1 |
p. 26-
1 p.
|
artikel
|
| 44 |
O-82. Goserelin plus Anastrozole as first-line endocrine therapy for premenopausal oestrogen receptor positive (ER+) advanced breast cancer (ABC)
|
|
|
2005
|
3 |
1 |
p. 26-27
2 p.
|
artikel
|
| 45 |
O-25. High dose oestrogen (HDE) as an endocrine therapy option for advanced breast cancer (ABC)
|
|
|
2005
|
3 |
1 |
p. 8-
1 p.
|
artikel
|
| 46 |
O-63. How Carlisle made the BASO database clinician friendly
|
|
|
2005
|
3 |
1 |
p. 20-
1 p.
|
artikel
|
| 47 |
O-72. Identification of oestrogen-regulated genes in human breast cancer cells using DNA microarrays
|
|
|
2005
|
3 |
1 |
p. 23-
1 p.
|
artikel
|
| 48 |
O-94. Impact of 11-gauge vacuum assisted biopsy (Mammotome) on accuracy of preoperative diagnosis of ductal carcinoma in situ (DCIS)
|
|
|
2005
|
3 |
1 |
p. 30-
1 p.
|
artikel
|
| 49 |
O-78. Importance of methodology in plasma oestradiol measurements: applications in breast cancer research and management
|
|
|
2005
|
3 |
1 |
p. 25-
1 p.
|
artikel
|
| 50 |
O-68. Incidence of intra-mammary (Intra-M) nodes in completion mastectomy specimens: implications for breast conserving surgery (BCS)
|
|
|
2005
|
3 |
1 |
p. 22-
1 p.
|
artikel
|
| 51 |
O-101. Increased risk of local relapse and decreased survival after breast conserving therapy (BCT) in the under 40's
|
|
|
2005
|
3 |
1 |
p. 32-
1 p.
|
artikel
|
| 52 |
O-27. Influence of hormone replacement therapy (HRT) on Tamoxifen induced menopausal symptoms
|
|
|
2005
|
3 |
1 |
p. 9-
1 p.
|
artikel
|
| 53 |
O-83. Inhibition of haematogenous micrometastasis using Tinzaparin small oligosaccharides of heparin
|
|
|
2005
|
3 |
1 |
p. 27-
1 p.
|
artikel
|
| 54 |
O-99. Intraoperative touch imprint cytology of clinically apparent sentinel node metastases: why bother?
|
|
|
2005
|
3 |
1 |
p. 31-32
2 p.
|
artikel
|
| 55 |
O-90. Is mammographic spiculation an independent good prognostic factor in screen detected invasive breast cancer?
|
|
|
2005
|
3 |
1 |
p. 29-
1 p.
|
artikel
|
| 56 |
O-115. Is there an optimal duration of neoadjuvant letrozole therapy?
|
|
|
2005
|
3 |
1 |
p. 36-37
2 p.
|
artikel
|
| 57 |
O-114. Letrozole and Anastrozole: a pre-operative study of their effects on ER positive breast cancers in postmenopausal women
|
|
|
2005
|
3 |
1 |
p. 36-
1 p.
|
artikel
|
| 58 |
O-43. Local recurrence after breast cancer screening
|
|
|
2005
|
3 |
1 |
p. 14-
1 p.
|
artikel
|
| 59 |
O-41. Local recurrence in surgically treated screen-detected breast cancer in Wales
|
|
|
2005
|
3 |
1 |
p. 13-14
2 p.
|
artikel
|
| 60 |
O-55. Management of lobular carcinoma in situ within the NHSBSP
|
|
|
2005
|
3 |
1 |
p. 18-
1 p.
|
artikel
|
| 61 |
O-120. Measurement of large scale genomic instability is an excellent prognostic tool in ductal carcinoma in situ
|
|
|
2005
|
3 |
1 |
p. 38-39
2 p.
|
artikel
|
| 62 |
O-15. Measuring quality in breast reconstruction — a simple and responsive scoring system
|
|
|
2005
|
3 |
1 |
p. 5-
1 p.
|
artikel
|
| 63 |
O-2. Microarray profiling and real time PCR validation of genes associated with Tamoxifen resistance
|
|
|
2005
|
3 |
1 |
p. 1-
1 p.
|
artikel
|
| 64 |
O-37. Modification of the Nottingham Prognostic Index by nodal status
|
|
|
2005
|
3 |
1 |
p. 12-
1 p.
|
artikel
|
| 65 |
O-13. Morbidity following sentinel lymph node biopsy in primary breast cancer — a randomised controlled trial
|
|
|
2005
|
3 |
1 |
p. 4-
1 p.
|
artikel
|
| 66 |
O-58. More breast conserving surgery (BCS) performed with saline instillation and fewer local relapses
|
|
|
2005
|
3 |
1 |
p. 19-
1 p.
|
artikel
|
| 67 |
O-23. Neoadjuvant letrozole is equally effective in Her 2 positive and negative breast cancers
|
|
|
2005
|
3 |
1 |
p. 7-8
2 p.
|
artikel
|
| 68 |
O-91. Nipple biopsies in Paget's disease of the breast: an 8 year retrospective study
|
|
|
2005
|
3 |
1 |
p. 29-
1 p.
|
artikel
|
| 69 |
O-77. Oestrogen receptor variant expression as potential selectors for adjuvant endocrine therapy in breast cancer patients
|
|
|
2005
|
3 |
1 |
p. 25-
1 p.
|
artikel
|
| 70 |
O-60. ONCOPOOL — a European dataset in 16893 cases of breast cancer
|
|
|
2005
|
3 |
1 |
p. 19-
1 p.
|
artikel
|
| 71 |
O-56. Optical diagnostics in ductal carcinoma in situ (DCIS) of the breast to differentiate between different grades of pathology
|
|
|
2005
|
3 |
1 |
p. 18-
1 p.
|
artikel
|
| 72 |
O-95. Outcome of screen-detected breast lesions with an indeterminate (B3) core biopsy
|
|
|
2005
|
3 |
1 |
p. 30-
1 p.
|
artikel
|
| 73 |
O-40. Overexpression of HER-2 in lymph nodes disease is an independent prognostic factor and identifies a very poor prognosis group not identified by NPI
|
|
|
2005
|
3 |
1 |
p. 13-
1 p.
|
artikel
|
| 74 |
O-57. Pain syndromes affect quality of life after mastectomy and breast conserving surgery
|
|
|
2005
|
3 |
1 |
p. 18-
1 p.
|
artikel
|
| 75 |
O-45. Positive lumpectomy margins: is re-excision always necessary?
|
|
|
2005
|
3 |
1 |
p. 14-15
2 p.
|
artikel
|
| 76 |
O-64. Post mastectomy radiotherapy index
|
|
|
2005
|
3 |
1 |
p. 20-21
2 p.
|
artikel
|
| 77 |
O-29. Predicting survival after 5 years of Tamoxifen
|
|
|
2005
|
3 |
1 |
p. 9-10
2 p.
|
artikel
|
| 78 |
O-38. Predicting survival in BRCA mutation carriers
|
|
|
2005
|
3 |
1 |
p. 12-13
2 p.
|
artikel
|
| 79 |
O-3. Prediction of hormone response in breast cancer by microarray analysis of sequential tumour biopsies from patients receiving neoadjuvant therapy with Letrozole
|
|
|
2005
|
3 |
1 |
p. 1-
1 p.
|
artikel
|
| 80 |
O-70. Pre-operative study of the tolerability of Faslodex and Tamoxifen in a group of pre-menopausal women
|
|
|
2005
|
3 |
1 |
p. 22-
1 p.
|
artikel
|
| 81 |
O-84. Primary Taxotere versus doxorubicin for breast cancer. Five year survival analysis
|
|
|
2005
|
3 |
1 |
p. 27-
1 p.
|
artikel
|
| 82 |
O-36. Prognosis after local/regional recurrence
|
|
|
2005
|
3 |
1 |
p. 12-
1 p.
|
artikel
|
| 83 |
O-106. Prognostic value of phosphorylated mitogen-activated protein kinase (aMAPK) in primary breast cancer
|
|
|
2005
|
3 |
1 |
p. 34-
1 p.
|
artikel
|
| 84 |
O-124. Regional recurrence (RR) after 4 axillary node sampling (4ANS)
|
|
|
2005
|
3 |
1 |
p. 40-
1 p.
|
artikel
|
| 85 |
O-73. Regulation of oestrogen receptor beta in MCF-7 breast cancer cells with Trilostane by comparative gene expression microarray analysis
|
|
|
2005
|
3 |
1 |
p. 23-24
2 p.
|
artikel
|
| 86 |
O-46. Relationship between presence of lobular carcinoma in situ and risk of local recurrence in patients with primary breast cancer treated with breast conserving surgery and radiotherapy
|
|
|
2005
|
3 |
1 |
p. 15-
1 p.
|
artikel
|
| 87 |
O-24. Response to further endocrine therapies following de novo or acquired resistance to first line endocrine therapy for advanced breast cancer
|
|
|
2005
|
3 |
1 |
p. 8-
1 p.
|
artikel
|
| 88 |
O-62. Results from the breast cancer clinica outcome measures (BCCOM) project: year 1 (2002 data)
|
|
|
2005
|
3 |
1 |
p. 20-
1 p.
|
artikel
|
| 89 |
O-18. Risk reducing mastectomy: a survey of current practice in the UK
|
|
|
2005
|
3 |
1 |
p. 6-
1 p.
|
artikel
|
| 90 |
O-17. Risk reducing mastectomy (RRM): high incidence of occult breast cancers
|
|
|
2005
|
3 |
1 |
p. 6-
1 p.
|
artikel
|
| 91 |
O-28. Routes of administration in breast cancer: preliminary findings from a patient survey
|
|
|
2005
|
3 |
1 |
p. 9-
1 p.
|
artikel
|
| 92 |
OS-1. Are conventional clinical markers outperformed by microarray gene expression profilers in breast cancer prognosis?
|
|
|
2005
|
3 |
1 |
p. 40-
1 p.
|
artikel
|
| 93 |
O-87. Seeing through “chemo-fog” — myth or reality
|
|
|
2005
|
3 |
1 |
p. 28-
1 p.
|
artikel
|
| 94 |
O-5. Sentinel lymph node biopsy for breast cancer: from investigational procedure to standard practice
|
|
|
2005
|
3 |
1 |
p. 2-
1 p.
|
artikel
|
| 95 |
O-8. Sentinel node assisted 4 node-sampling
|
|
|
2005
|
3 |
1 |
p. 3-
1 p.
|
artikel
|
| 96 |
O-11. Sentinel node biopsy in early breast cancer and its role in nodal micrometastasis: experience at national university hospital, singapore
|
|
|
2005
|
3 |
1 |
p. 4-
1 p.
|
artikel
|
| 97 |
O-104. Should computerised tomography (CT) replace abdominal ultrasonography and chest radiography (USG + CXR) as initial staging investigation for visceral disease in patients with metastatic breast cancer (MBC)?
|
|
|
2005
|
3 |
1 |
p. 33-
1 p.
|
artikel
|
| 98 |
O-69. Surgeons' views on multi-disciplinary breast
|
|
|
2005
|
3 |
1 |
p. 22-
1 p.
|
artikel
|
| 99 |
O-30. Survival of elderly patients with breast cancer treated with primary Tamoxifen therapy
|
|
|
2005
|
3 |
1 |
p. 10-
1 p.
|
artikel
|
| 100 |
O-111. Switching to anastrozole (ANA) vs continued Tamoxifen (TAM) treatment of early breast cancer (EBC). Updated results of the Italian Tamoxifen Anastrozole (ITA) trial
|
|
|
2005
|
3 |
1 |
p. 35-
1 p.
|
artikel
|
| 101 |
O-19. Systemic cavity shaves reduces positive margins and re-excision rates in breast conserving surgery
|
|
|
2005
|
3 |
1 |
p. 6-
1 p.
|
artikel
|
| 102 |
O-61. The 2003/04 ABS at BASO audit
|
|
|
2005
|
3 |
1 |
p. 20-
1 p.
|
artikel
|
| 103 |
O-100. The BASO II trial of primary treatment of tumours of excellent prognosis: 2005 update
|
|
|
2005
|
3 |
1 |
p. 32-
1 p.
|
artikel
|
| 104 |
O-102. The effect on survival of local recurrence (LR) after breast conserving surgery
|
|
|
2005
|
3 |
1 |
p. 32-33
2 p.
|
artikel
|
| 105 |
O-26. The effects of Faslodex and Tamoxifen in premenopausal breast cancer
|
|
|
2005
|
3 |
1 |
p. 9-
1 p.
|
artikel
|
| 106 |
O-50. The expression of apoptosis-regulating proteins in usual ductal hyperplasia with known outcome
|
|
|
2005
|
3 |
1 |
p. 16-
1 p.
|
artikel
|
| 107 |
O-92. The frequency of breast cancer screening: results of a randomised trial
|
|
|
2005
|
3 |
1 |
p. 29-30
2 p.
|
artikel
|
| 108 |
O-110. The growth rate of breast cancers in the observed phase according to grade
|
|
|
2005
|
3 |
1 |
p. 35-
1 p.
|
artikel
|
| 109 |
O-117. The influence of tumour grade on DCIS stem cell growth
|
|
|
2005
|
3 |
1 |
p. 37-
1 p.
|
artikel
|
| 110 |
O-80. The introduction of better therapies lengthened survival in advanced breast cancer
|
|
|
2005
|
3 |
1 |
p. 26-
1 p.
|
artikel
|
| 111 |
O-109. Therapeutic mammaplasty — approach to planning and techniques
|
|
|
2005
|
3 |
1 |
p. 35-
1 p.
|
artikel
|
| 112 |
O-107. Therapeutic mammaplasty — audit of outcome
|
|
|
2005
|
3 |
1 |
p. 34-
1 p.
|
artikel
|
| 113 |
O-20. The role of the breast care nurse (BCN) specialists in giving results to patients
|
|
|
2005
|
3 |
1 |
p. 6-7
2 p.
|
artikel
|
| 114 |
O-44. The significance of the in situ component of a positive margin in breast-conserving therapy in breast cancer
|
|
|
2005
|
3 |
1 |
p. 14-
1 p.
|
artikel
|
| 115 |
O-10. The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
|
|
|
2005
|
3 |
1 |
p. 3-4
2 p.
|
artikel
|
| 116 |
O-48. Timing of radiotherapy and survival in breast-conserving therapy
|
|
|
2005
|
3 |
1 |
p. 15-16
2 p.
|
artikel
|
| 117 |
O-86. Trastuzumab and CerbB2 positive brain metastases — treatment synergy leading to longer survival?
|
|
|
2005
|
3 |
1 |
p. 28-
1 p.
|
artikel
|
| 118 |
O-1. Trends in prognosis of patients with primary metastatic breast cancer between 1975 and 2002
|
|
|
2005
|
3 |
1 |
p. 1-
1 p.
|
artikel
|
| 119 |
O-31. Trial of mastectomy versus Tamoxifen for treating elderly patients with operable breast cancer — results after a 20 year follow up
|
|
|
2005
|
3 |
1 |
p. 10-
1 p.
|
artikel
|
| 120 |
O-98. Triple assessment of every focal asymmetrical palpable breast lesion is unnecessary in the presence of normal imaging
|
|
|
2005
|
3 |
1 |
p. 31-
1 p.
|
artikel
|
| 121 |
O-71. Upregulation of CD44S and variants in anti-hormone resistant breast cancer cells
|
|
|
2005
|
3 |
1 |
p. 23-
1 p.
|
artikel
|
| 122 |
O-33. Validation of the Nottingham Prognostic Index (NPI) in a district general hospital (DGH) in the UK
|
|
|
2005
|
3 |
1 |
p. 11-
1 p.
|
artikel
|
| 123 |
O-96. Variations in detection rates of benign screen-detected radial scars/complex sclerosing lesions
|
|
|
2005
|
3 |
1 |
p. 30-31
2 p.
|
artikel
|
| 124 |
O-35. Young age is not an independent prognostic factor
|
|
|
2005
|
3 |
1 |
p. 11-12
2 p.
|
artikel
|
| 125 |
O-34. Young women with breast cancer; clinical, histopathological and prognostic considerations
|
|
|
2005
|
3 |
1 |
p. 11-
1 p.
|
artikel
|
| 126 |
O-79. Zinc-dependant activation of C-SRC, EGFR and IGF-1R mitogenic pathways in Tamoxifen-resistant
|
|
|
2005
|
3 |
1 |
p. 25-26
2 p.
|
artikel
|
Tijdschrift beschrijving